Chemotherapy and Radiotherapy to Treat Patients With Limited Stage of Small Cell Lung Cancer (SCLC)
Clinical trial NCT00494026 · TERMINATED
Trial details
- NCT number
- NCT00494026
- Sponsor
- Eli Lilly and Company
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2007-09-01
- Primary completion
- 2008-10-01
- Enrollment
- 4
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.